Tokyo / Geneva / Dublin / Charlottenlund / Rabat / Makati City / Uppsala / Mumbai / /
Company
WHO 5 Chapter 3 Partners / Pharmacovigilance / /
Country
Switzerland / United States / Canada / United Kingdom / Sweden / South Africa / New Zealand / /
Event
Bankruptcy / Man-Made Disaster / /
Facility
KEM Hospital / GS Medical College / University of Cape Town / /
IndustryTerm
prescription event monitoring systems / record linkage systems / active surveillance systems / pharmaceutical industry / blood products / pharmaceutical and similar products / natural products / healthcare / pharmaceutical manufacturers / established regulatory infrastructure / chemicals / medicinal products / food / /
MedicalCondition
Back Malaria / acute and chronic poisoning / injury / /
World Health Organization / Uppsala Monitoring Centre / WHO Department of Essential Drugs and Medicines in Geneva / WHO Programme / KEM Hospital / Institut Nationale d’Hygiène / International Society / Introduction CHAPTER / World Health Assembly / GS Medical College / European Society of Pharmacovigilance / Medicines Board / office of Publications / WHO Collaborating Centre for International Drug Monitoring / International Society of Pharmacoepidemiology / WHO Collaborating Centre for International Drug Monitoring TABLE OF CONTENTS Contents Page Preface / national drug regulatory authority / University of Cape Town / Cape Town / Ministry of Health / participating in the WHO Programme / /
The IMPORTANCE of PHARMACOVIGILANCE Safety Monitoring of medicinal products World Health